Joshua Leitch Bonkowsky, MD, PhD

Languages Spoken: English, German

Dr. Josh Bonkowsky is a professor of Pediatric Neurology (Pediatrics) and Division Chief. He is the Director of Primary Children's Hospital Center for Personalized Medicine and is co-director of the Primary Children's Brain and Spine Center. His undergraduate training was at Harvard University; he obtained his MD and PhD degrees at the University of California, San Diego, and did his Pediatrics and Neurology/Pediatric Neurology training at the University of Utah and Boston Children's Hospital. Dr. Bonkowsky is engaged in both clinical and basic science studies. His clinical studies are focused on understanding the clinical features of leukodystrophies, and on the genetics of complex human neurobehavioral traits, especially the effects of premature birth on brain connectivity. Dr. Bonkowsky's clinical research group is involved clinical trials for leukodystrophies; investigating the genetics of leukodystrophies using local (Utah Population Database) and national databases, to understand the genetic and medical impacts of these disorders. Research in the Bonkowsky laboratory investigates human neurogenetic diseases, including leukodystrophies and connectivity disorders. His group is involved in gene therapy development; has developed zebrafish models of human diseases; and is involved in generating disease models for high-throughput drug discovery. On sunny afternoons, Dr. Bonkowsky enjoys trail running and learning to skate ski.

Dr. Josh Bonkowsky is an associate professor of Pediatric Neurology (Pediatrics) and of Neurology. His undergraduate training was at Harvard University; he obtained his MD and PhD degrees at the University of California, San Diego, and did his Pediatrics and Neurology/Pediatric Neurology training at the University of Utah and Boston Children's Hospital.

Dr. Bonkowsky is engaged in both clinical and basic science studies. His clinical studies are focused on understanding the clinical features of leukodystrophies, and on the genetics of complex human neurobehavioral traits, especially language impairments. Dr. Bonkowsky's clinical research group is investigating the genetics of leukodystrophies, using both local (Utah Population Database) and national databases, to understand the genetic and medical impacts of these disorders.

Research in the Bonkowsky laboratory investigates human neurogenetic diseases, specifically diseases of basal ganglia function and white matter diseases. His group has developed zebrafish models of human language disorders (the FOXP2 gene); transgenic lines to study basal ganglia development connectivity; and a zebrafish Parkinson's disease model. Besides the basic neurodevelopmental research, his lab is generating disease models for high-throughput drug discovery.

On sunny afternoons, Dr. Bonkowsky enjoys trail running and learning to skate ski.

Dr. Josh Bonkowsky is a professor of Pediatric Neurology (Pediatrics) and Division Chief. He is the Director of Primary Children's Hospital Center for Personalized Medicine and is co-director of the Primary Children's Brain and Spine Center. His undergraduate training was at Harvard University; he obtained his MD and PhD degrees at the University of California, San Diego, and did his Pediatrics and Neurology/Pediatric Neurology training at the University of Utah and Boston Children's Hospital. Dr. Bonkowsky is engaged in both clinical and basic science studies. His clinical studies are focused on understanding the clinical features of leukodystrophies, and on the genetics of complex human neurobehavioral traits, especially the effects of premature birth on brain connectivity. Dr. Bonkowsky's clinical research group is involved clinical trials for leukodystrophies; investigating the genetics of leukodystrophies using local (Utah Population Database) and national databases, to understand the genetic and medical impacts of these disorders. Research in the Bonkowsky laboratory investigates human neurogenetic diseases, including leukodystrophies and connectivity disorders. His group is involved in gene therapy development; has developed zebrafish models of human diseases; and is involved in generating disease models for high-throughput drug discovery. On sunny afternoons, Dr. Bonkowsky enjoys trail running and learning to skate ski.

Dr. Josh Bonkowsky is an associate professor of Pediatric Neurology (Pediatrics) and of Neurology. His undergraduate training was at Harvard University; he obtained his MD and PhD degrees at the University of California, San Diego, and did his Pediatrics and Neurology/Pediatric Neurology training at the University of Utah and Boston Children's Hospital.

Dr. Bonkowsky is engaged in both clinical and basic science studies. His clinical studies are focused on understanding the clinical features of leukodystrophies, and on the genetics of complex human neurobehavioral traits, especially language impairments. Dr. Bonkowsky's clinical research group is investigating the genetics of leukodystrophies, using both local (Utah Population Database) and national databases, to understand the genetic and medical impacts of these disorders.

Research in the Bonkowsky laboratory investigates human neurogenetic diseases, specifically diseases of basal ganglia function and white matter diseases. His group has developed zebrafish models of human language disorders (the FOXP2 gene); transgenic lines to study basal ganglia development connectivity; and a zebrafish Parkinson's disease model. Besides the basic neurodevelopmental research, his lab is generating disease models for high-throughput drug discovery.

On sunny afternoons, Dr. Bonkowsky enjoys trail running and learning to skate ski.